Stock Scorer

Quantum Biopharma Ltd. (QNTM)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. This filer's financial year end could not be read from its revenue history, so quarters are labelled by the calendar. Amounts in USD. Every figure as a table ›

Operating Income Annual

-45M -30M -15M 0 15M 30M 45M 2021: -33.7M 2022: -27.4M 2023: -23.8M 2024: -16.1M 2025: -15.3M 2021 2022 2023 2024 2025

Net Income Annual

-45M -30M -15M 0 15M 30M 45M 2019: -39.1M 2019: -39.1M 2020: -31.8M 2021: -35.3M 2022: -23.6M 2019 2019 2020 2021 2022

Operating Cash Flow Annual

-30M -20M -10M 0 10M 20M 30M 2021: -20.7M 2022: -28.3M 2023: -10.8M 2024: -6.9M 2025: -8.2M 2021 2022 2023 2024 2025

Free Cash Flow Annual

-30M -20M -10M 0 10M 20M 30M 2020: -19.1M 2021: -20.7M 2022: -28.4M 2023: -10.8M 2024: -6.9M 2020 2021 2022 2023 2024

Operating cash flow minus capital expenditure.

Shares Outstanding Annual

0 15M 30M 45M 2020: 12M 2021: 34.9M 2022: 595.9K 2023: 609.1K 2024: 1.1M 2020 2021 2022 2023 2024

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

Not drawn for QNTM: Revenue, Gross Profit, Cost of Revenue, EPS. Nothing in this filer's XBRL supports them for the periods asked for. That is a gap in the filing, not a zero, and drawing a flat line would be an invention.